- Home
- BALY vs IOVA Comparison
BALY vs IOVA Comparison
Compare BALY & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BALY
- IOVA
- Stock Information
- Founded
- BALY 2004
- IOVA 2007
- Country
- BALY United States
- IOVA United States
- Employees
- BALY 10000
- IOVA N/A
- Industry
- BALY Hotels/Resorts
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BALY Consumer Discretionary
- IOVA Health Care
- Exchange
- BALY Nasdaq
- IOVA Nasdaq
- Market Cap
- BALY 737.4M
- IOVA 771.4M
- IPO Year
- BALY N/A
- IOVA N/A
- Fundamental
- Price
- BALY $9.91
- IOVA $3.13
- Analyst Decision
- BALY Hold
- IOVA Buy
- Analyst Count
- BALY 7
- IOVA 10
- Target Price
- BALY $18.00
- IOVA $12.22
- AVG Volume (30 Days)
- BALY 363.4K
- IOVA 23.7M
- Earning Date
- BALY 02-19-2025
- IOVA 08-07-2025
- Dividend Yield
- BALY N/A
- IOVA N/A
- EPS Growth
- BALY N/A
- IOVA N/A
- EPS
- BALY N/A
- IOVA N/A
- Revenue
- BALY $2,481,783,000.00
- IOVA $212,679,000.00
- Revenue This Year
- BALY $3.06
- IOVA $86.62
- Revenue Next Year
- BALY N/A
- IOVA $69.95
- P/E Ratio
- BALY N/A
- IOVA N/A
- Revenue Growth
- BALY 2.80
- IOVA 11070.12
- 52 Week Low
- BALY $9.74
- IOVA $1.64
- 52 Week High
- BALY $18.38
- IOVA $12.51
- Technical
- Relative Strength Index (RSI)
- BALY 46.11
- IOVA 62.71
- Support Level
- BALY $9.70
- IOVA $1.70
- Resistance Level
- BALY $10.25
- IOVA $4.33
- Average True Range (ATR)
- BALY 0.61
- IOVA 0.35
- MACD
- BALY -0.06
- IOVA 0.17
- Stochastic Oscillator
- BALY 20.50
- IOVA 54.55
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.